10 medicines held by Norgine B.V. on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Agilus 120 mg powder for solution for injection EU/1/24/1805/001-002 |
Dantrolene Sodium, Hemiheptahydrate | Norgine B.V. | — |
| Angusta 25 microgram tablets PA1336/010/001 |
Misoprostol | Norgine B.V. | Not marketed |
| Dantrium 100 mg Capsules PA1336/004/002 |
Dantrolene sodium | Norgine B.V. | Not marketed |
| Dantrium 25 mg Capsules PA1336/004/001 |
Dantrolene sodium | Norgine B.V. | Marketed |
| Feraccru 30 mg hard capsules EU/1/15/1075/001-004 |
Ferric maltol | Norgine B.V. | — |
| Moviprep Orange, powder for oral solution PA1336/001/002 |
Macrogol 3350, Sodium sulfate anhydrous, Sodium chloride, Potassium chloride, Ascorbic acid | Norgine B.V. | Not marketed |
| Moviprep, powder for oral solution PA1336/001/001 |
Macrogol 3350, Sodium sulfate anhydrous, Sodium chloride, Potassium chloride, Ascorbic acid | Norgine B.V. | Marketed |
| Pedmarqsi 80 mg/mL solution for infusion EU/1/23/1734/001 |
Sodium thiosulfate | Norgine B.V. | — |
| Plenvu powder for oral solution PA1336/005/001 |
Macrogol 3350, Sodium sulfate anhydrous, Sodium chloride, Potassium chloride, Macrogol 3350 | Norgine B.V. | Marketed |
| Targaxan 550 mg film-coated tablets PA1336/009/001 |
Rifaximin | Norgine B.V. | Marketed |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 12 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.